Loading…

Loading grant details…

Active BIOIMAGING TECHNOLOGY DEVELOPMENT AWARD Europe PMC

Organ-Cell-Molecular Imaging (OCMI): Integrating Human Heart Bioimaging Across Scales Using Foundation Models

£5.02M GBP

Funder Wellcome Trust
Recipient Organization University College London
Country United Kingdom
Start Date Oct 01, 2024
End Date Mar 31, 2026
Duration 546 days
Number of Grantees 1
Roles Award Holder
Data Source Europe PMC
Grant ID 310796
Grant Description

HOW TO MAP A WHOLE HUMAN ORGAN AT MOLECULAR RESOLUTION ?

We will develop a multi-modal bioimaging platform to enable Organ to Cell to Molecular Imaging (OCMI), using machine learning (ML) to link two novel techniques: high definition spatial multi-omics and hierarchical phase-contrast tomography (HiP-CT).

In the Foundation phase, our focus will be on developing techniques, demonstrating feasibility, and expanding collaborations.

In scale-up, we will further advance imaging techniques, validate and refine ML models, and extend applications to disease, dynamics, and other organs.

To showcase the potential of integrating bioimaging across scales, we will investigate the 'connectomics' of the human heart at both structural and molecular levels.

This will shed light on tissue and organ engineering, by mapping both gene expression and structural architecture in 3D.

Central to our programme is making phase-contrast imaging accessible to all by bringing HiP-CT into laboratories and leveraging virtual platforms for partnership and dissemination.

We believe that connecting morphology-based imaging with molecular modalities across scales, technologies, and disciplines will have an impact on human health, medical education, and public engagement.

All Grantees

University College London

Advertisement
Apply for grants with GrantFunds
Advertisement
Browse Grants on GrantFunds
Interested in applying for this grant?

Complete our application form to express your interest and we'll guide you through the process.

Apply for This Grant